2024 News

Mrig
Emily A. Hammad Mrig, PhD, is using natural language processing (NLP) to identify patients and solutions that make molecular diagnostics more affordable and equitable.
Giacomini, Manglik, Krogan and Shoichet
The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the school’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.
Manglik
Department of Pharmaceutical Chemistry faculty member Aashish Manglik, MD, PhD, was celebrated as a curiosity-driven scientist in the 29th annual Byers Award Lecture, where he shared how he fulfilled a research dream in his journey from Stanford University to UCSF.
Morris
David Morris, MD, has worked with many Bay Area startups, including a spin-off from the lab of Department of Pharmaceutical Chemistry faculty member Jim Wells, PhD.
Sello and Shoichet
Department of Pharmaceutical Chemistry faculty members Brian Shoichet, PhD, and Jason Sello, PhD, combine collaboration, curiosity, and innovation to discover molecules that can become anesthetics administered without specialized training.
Hart and Arkin.
Charles Hart, PhD, director of the Catalyst Program, joins Department of Pharmaceutical Chemistry Chair Michelle Arkin in the center’s ongoing collaboration with academics, government labs, and pharmaceutical companies to develop drug leads that address unmet medical needs.
Ruben Hogan speaks in front of graphics on screen.
Three students with ties to the School were finalists in the event, which challenges graduate students to explain their research to an audience of non-experts in just three minutes.
women in a laboratory discuss a project.
School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.
Manglik
The GPCR and neuropsychiatric diseases researcher will receive $1.25 million over five years to explore new territory.